NIR‐II AIE Liposomes for Boosting Type‐I Photodynamic and Mild‐Temperature Photothermal Therapy in Breast Cancer Treatment
Shijie Zhen,
No information about this author
Zhe Xu,
No information about this author
Meng Suo
No information about this author
et al.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 26, 2024
Abstract
Phototheranositcs
has
recently
aroused
extreme
attention
due
to
its
exceptional
advantages.
However,
the
poor
photothernostic
efficiency,
limited
penetration
depth,
strong
oxygen‐dependence,
and
inevitable
damage
normal
tissue
of
conventional
materials
severely
hindered
their
total
theranostic
efficacy.
Herein,
a
series
near‐infrared
second
(NIR‐II)
photosensitizers
(PSs)
featuring
aggregation‐induced
emission
(AIE),
NIR‐II
fluorescence
imaging
(FLI),
type
I
photodynamic
therapy
(PDT)
mild‐temperature
photothermal
(PTT)
are
constructed
through
dual‐strategy
methods
combining
donor
group
engineering
fluorination
engineering.
Profiting
from
sufficient
molecular
rotors
high
electronegativity
fluorine,
developed
2‐(2‐((5‐(4‐((4‐(diphenylamino)phenyl)(phenyl)amino)phenyl)thiophen‐2‐yl)methylene)‐5,6‐difluoro‐3‐oxo‐2,3‐dihydro‐1H‐inden‐1‐ylidene)malononitrile
(BTS‐2F)
2‐(2‐((5‐(4‐(bis(4‐(diphenylamino)phenyl)amino)phenyl)thiophen‐2‐yl)methylene)‐5,6‐difluoro‐3‐oxo‐2,3‐dihydro‐1H‐inden‐1‐ylidene)malononitrile
(TTS‐2F)
endowed
with
AIE
property,
radical
reactive
oxygen
species
(ROS)
generation
ability
conversion.
Through
thin
film
hydration
method,
prepared
BTS‐2F
TTS‐2F
loaded
liposomes
exhibit
significant
FLI
improved
type‐I
PDT/mild‐temperature
PTT
under
laser
irradiation
both
in
vitro
orthotopic
4T1
mice
models.
Language: Английский
Endogenous Near‐Infrared Chemiluminescence: Imaging‐Guided Non‐Invasive Thrombolysis and Anti‐Inflammation Based on a Heteronuclear Transition Metal Complex
Ziwei Wang,
No information about this author
Bo Zhu,
No information about this author
Wei Nie
No information about this author
et al.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
Conventional
therapy
to
treat
thrombi
(blood
clots)
has
significant
limitations:
i)
inflammation;
ii)
bleeding
side
effects;
iii)
re-embolisation,
and
iv)
in
situ
that
are
not
visible.
Here
it
is
reported
Cu2Ir
nanoparticles
(NPs)
with
a
Cu-coordinated
tetraphenylporphyrin
(TPP)
core
cyclometalated
Ir(C^N)2(N^N)
substituents
integrate
long-lived
near-infrared
(NIR)
chemiluminescence
(CL)
imaging,
photothermal
(PTT)
photodynamic
(PDT)
for
thrombolysis,
antioxidant
anti-inflammatory
properties.
Based
on
density
functional
theory
calculations
the
chemiluminescent
reaction
site
between
TPP
peroxynitrite
(ONOO-)
confirmed
first
time.
The
presence
of
transition
metal
significantly
improves
properties
TPP.
Upon
specific
activation
by
ONOO-,
NPs
exhibited
more
than
30-fold
NIR
CL
intensity
NPs,
luminescence
lasted
60
min
allowing
precise
long-lasting
dynamic
tracking
thrombi.
achieved
non-invasive
safe
thrombolytic
triggered
irradiation
at
signaling
site.
72.3%
blood
reperfusion
obtained
nearly
complete
restoration
flow,
re-embolism
prevented
mouse
carotid
artery
model.
Furthermore,
scavenged
excess
reactive
oxygen/nitrogen
species
(RONS)
reduced
inflammatory
factors.
hold
promise
as
single-molecule
strategy
diagnosing
treating
diseases
associated
thrombosis.
Language: Английский
Polypeptide nanoparticles obstruct glucose supply for NIR-II fluorescence-guided tumor starvation and enhanced mild photothermal therapy
Yating Wang,
No information about this author
Yixuan Xu,
No information about this author
Dejia Chen
No information about this author
et al.
Acta Biomaterialia,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Language: Английский
Glucose oxidase-embedded mesoporous polydopamine nanoparticles produce CO for synergistic tumor starvation, chemodynamic, and photothermal therapy
Lingli Guo,
No information about this author
Nan Wang,
No information about this author
Yuqin Zhang
No information about this author
et al.
Colloids and Surfaces B Biointerfaces,
Journal Year:
2025,
Volume and Issue:
unknown, P. 114729 - 114729
Published: April 1, 2025
Language: Английский
Engineering a Near-Infrared Spiro-Based Aggregation-Induced Emission Luminogen for DNAzyme-Sensitized Photothermal Therapy with High Efficiency and Accuracy
Journal of the American Chemical Society,
Journal Year:
2024,
Volume and Issue:
146(51), P. 35462 - 35477
Published: Dec. 12, 2024
Aggregation-induced
emission
luminogen
(AIEgens)-based
photothermal
therapy
(PTT)
has
grown
into
a
sparkling
frontier
for
tumor
ablation.
However,
challenges
remain
due
to
the
uncoordinated
photoluminescence
(PL)
and
properties
of
classical
AIEgens,
along
with
hyperthermia-induced
antiapoptotic
responses
in
cells,
hindering
satisfactory
therapeutic
outcomes.
Herein,
near-infrared
(NIR)
spiro-AIEgen
TTQ-SA
was
designed
boosted
PTT
by
auxiliary
DNAzyme-regulated
cell
sensitization.
unique
molecular
structure
packing
mode
initially
fabricated,
endowing
it
strong
AIE
effect,
favorable
PL
quantum
yield,
good
performance.
DNAzyme,
as
gene
silencing
tool,
could
alleviate
antiapoptosis
response
during
PTT.
By
integrating
DNAzyme
folate-modified
poly(lactic-co-glycolic
acid)
(PLGA)
polymer,
as-fabricated
nanosystem
promote
apoptosis
sensitize
cells
PTT,
thereby
maximizing
With
combination
spiro-AIEgen-based
DNAzyme-based
silencing,
as-designed
showed
promising
NIR
imaging
abilities
targeting
demonstrated
significant
apoptotic,
antitumor,
antimetastasis
effects
against
orthotopic
breast
cancer.
Furthermore,
synergistic
antitumor
effect
realized
spontaneous
MMTV-PyMT
transgenic
mice.
These
findings
offer
new
insights
AIEgen-based
theranostics
sensitization,
paving
way
silencing-PTT
nanoplatforms
clinical
research.
Language: Английский
A Novel Delivery System for the Combined Use of Natural Ingredients: The Preparation of Berberine Hydrochloride–Matrine Liposomes and Preliminary Exploration of Their Anti-Tumor Activity
Min Xu,
No information about this author
Zhangkai Ye,
No information about this author
Junjing Liu
No information about this author
et al.
Molecules,
Journal Year:
2024,
Volume and Issue:
29(21), P. 5210 - 5210
Published: Nov. 4, 2024
Berberine
hydrochloride
(BH)
extracted
from
Coptis
chinensis
(CC)
and
Matrine
(MT)
separated
Sophora
flavescens
(SF)
are
alkaloids
with
potent
anti-bacterial,
anti-inflammatory,
anti-tumor
effects.
Motivated
by
the
clinical
practice
of
using
CC
SF
together,
we
aimed
to
demonstrate
that
synergistic
application
natural
compounds
BH
MT
could
enhance
therapeutic
effects
minimize
side
Two
types
liposomes,
liposomes
containing
only
(BH-LP)
both
(BH-MT-LP),
were
successfully
prepared
via
reverse
evaporation
method.
The
liposome
preparation
process
was
optimized
single-factor
screening
Box–Behnken
experimental
design
results
showed
had
particle
sizes
in
range
222.7
235.4
nm,
polydispersity
indicated
11.8%
23.3%,
zeta
potentials
−35.9
−31.1
mv.
BH-MT-LP
superior
activity
against
MDA-MB-231,
HepG-2,
HGC-27
cells
vitro.
incorporation
effectively
promoted
effect
BH,
while
controlled
release
further
enhanced
efficacy
BH.
Furthermore,
based
on
flow
cytometry
results,
speculated
might
promote
apoptosis
blocking
G1
phase
inducing
cell
death.
In
conclusion,
provides
evidence
for
combined
use
as
a
stable,
safe,
practical
drug
delivery
system
treatment
potential
cancers.
Meanwhile,
successful
also
new
approach
traditional
Chinese
medicine
ingredients.
Language: Английский